Popis: |
Cost-effectiveness of the introduction of a risk stratified population screening for type 2 diabetes in Hungary Zsolyom A1,5, Nagy B1,2, Dessewffy Z6, Steiner T3,4,5, Kalo Z1,2, Voko Z1,2 Working affiliation : 1. Syreon Research Institute; 2. Department of Health Policy and Health Economics, Eotvos Lorand University; 3. St. John's Hospital and North-Buda United Institutions, 2nd Dept. Intern. Med.-Diabetology; 4. St. Christopher's Clinic, Department of Endocrinology; 5. Faculty of Social Sciences, Social Policy Ph.D. Programme, Eotvos Lorand University; 6. Novartis Hungary |